Gattaca Genomics Launches Landmark Study to Revolutionize Embryo Selection in IVF
Summary
The study is currently recruiting IVF centers interested in participating, by collaborating with clinics worldwide, Gattaca Genomics aims to collect a large and diverse dataset that will provide valuable insights into the complex relationship between embryo development and aneuploidy. "Aneuploidy is a major obstacle for many couples pursuing IVF, and we believe this study has the potential to unlock new insights into how we can better identify and select embryos with the greatest chance of resulting in a healthy pregnancy," said Dr. Eva Schenkman, Director of Embryology Services at Gattaca Genomics. Gattaca Genomics aims to address these limitations by leveraging its extensive network of partner clinics to collect data from multiple sites, creating a robust dataset that combines timelapse imaging with next-generation sequencing. "This study represents a truly collaborative effort, uniting IVF clinics in the pursuit of scientific discovery and improved patient care," said Dr. Tyl Taylor, Director of Genetic Services at Gattaca Genomics. By harnessing the power of advanced technology, Gattaca Genomics is transforming family planning, offering sophisticated solutions that enhance the chances of a healthy pregnancy while minimizing genetic risks.